Jeffrey W. Albers
2018
Compensation breakdown
| Non-Equity Incentive Plan | $309,534 |
|---|---|
| Option Awards | $8,881,871 |
| Salary | $541,144 |
| Other | $8,250 |
| Total | $9,740,799 |
Albers received $8.9M in option awards, accounting for 91% of the total pay in 2018.
Albers also received $309.5K in non-equity incentive plan, $541.1K in salary and $8.3K in other compensation.
Rankings
In 2018, Jeffrey W. Albers' compensation ranked 719th out of 14,244 executives tracked by ExecPay. In other words, Albers earned more than 95.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 719 out of 14,244 | 95th |
Division Manufacturing | 235 out of 5,765 | 96th |
Major group Chemicals And Allied Products | 65 out of 2,128 | 97th |
Industry group Drugs | 49 out of 1,817 | 97th |
Industry Pharmaceutical Preparations | 35 out of 1,391 | 98th |
Pay ratio
| Jeffrey W. Albers' Pay | $9,740,799 |
|---|---|
| Median Employee's Pay | $398,087 |
| Pay Ratio | 24to 1 |
In 2018, the annual total compensation of Jeffrey W. Albers was $9,740,799.
The annual total compensation of the median employee at Blueprint Medicines was $398,087.
The ratio of Jeffrey W. Albers' pay to the pay of median employee was therefore 24 to one.
Albers' colleagues
We found five more compensation records of executives who worked with Jeffrey W. Albers at Blueprint Medicines in 2018.
2018
Christina Rossi
Blueprint Medicines
Chief Commercial Officer
2018
Anthony Boral
Blueprint Medicines
Chief Medical Officer
2018
Tracey McCain
Blueprint Medicines
Chief Legal and Compliance Officer
2018
Kathryn Haviland
Blueprint Medicines
Chief Operating Officer
2018
Michael Landsittel
Blueprint Medicines